An excerpt of 2022 European Association for the Study of the Liver clinical practice guidelines on the management of cystic liver diseases
10.3760/cma.j.cn311367-20221104-00550
- VernacularTitle:《2022年欧洲肝病学会临床实践指南：囊性肝病的管理》摘译
- Author:
Jie YUAN
1
;
Guohong HAN
Author Information
1. 西安国际医学中心医院消化与介入血管外科，西安 710100
- Keywords:
Cystic liver diseases;
Simple hepatic cysts;
Mucinous cystic neoplasms of the liver;
Polycystic liver;
Caroli disease;
Caroli syndrome;
Biliary hamartomas
- From:
Chinese Journal of Digestion
2022;42(12):803-807
- CountryChina
- Language:Chinese
-
Abstract:
The advent of enhanced radiological imaging techniques has facilitated the diagnosis of cystic liver lesions. Concomitantly, the evidence base supporting the management of these diseases has matured over the last decades. As a result, comprehensive clinical guidance on the subject matter is warranted. This guideline covers the diagnosis and management of hepatic cysts, mucinous cystic neoplasms of the liver, biliary hamartomas, polycystic liver disease, caroli disease, caroli syndrome, biliary hamartomas and peribiliary cysts. On the basis of in-depth review of the relevant literature, this guideline provide recommendations to navigate clinical dilemmas followed by supporting text. The recommendations are graded according to the Oxford Centre for Evidence-Based Medicine system and categorized as "weak" or "strong" . This guideline aims to provide the best available evidence to aid the clinical decision-making process in the management of patients with cystic liver disease, and presents the readers with translations and summarizations of the above mentioned recommendations.
